HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.

AbstractOBJECTIVE:
To examine the association between pre-diagnostic circulating vitamin D concentration, dietary intake of vitamin D and calcium, and the risk of colorectal cancer in European populations.
DESIGN:
Nested case-control study. Setting The study was conducted within the EPIC study, a cohort of more than 520 000 participants from 10 western European countries.
PARTICIPANTS:
1248 cases of incident colorectal cancer, which developed after enrolment into the cohort, were matched to 1248 controls
MAIN OUTCOME MEASURES:
Circulating vitamin D concentration (25-hydroxy-vitamin-D, 25-(OH)D) was measured by enzyme immunoassay. Dietary and lifestyle data were obtained from questionnaires. Incidence rate ratios and 95% confidence intervals for the risk of colorectal cancer by 25-(OH)D concentration and levels of dietary calcium and vitamin D intake were estimated from multivariate conditional logistic regression models, with adjustment for potential dietary and other confounders.
RESULTS:
25-(OH)D concentration showed a strong inverse linear dose-response association with risk of colorectal cancer (P for trend <0.001). Compared with a pre-defined mid-level concentration of 25-(OH)D (50.0-75.0 nmol/l), lower levels were associated with higher colorectal cancer risk (<25.0 nmol/l: incidence rate ratio 1.32 (95% confidence interval 0.87 to 2.01); 25.0-49.9 nmol/l: 1.28 (1.05 to 1.56), and higher concentrations associated with lower risk (75.0-99.9 nmol/l: 0.88 (0.68 to 1.13); >or=100.0 nmol/l: 0.77 (0.56 to 1.06)). In analyses by quintile of 25-(OH)D concentration, patients in the highest quintile had a 40% lower risk of colorectal cancer than did those in the lowest quintile (P<0.001). Subgroup analyses showed a strong association for colon but not rectal cancer (P for heterogeneity=0.048). Greater dietary intake of calcium was associated with a lower colorectal cancer risk. Dietary vitamin D was not associated with disease risk. Findings did not vary by sex and were not altered by corrections for season or month of blood donation.
CONCLUSIONS:
The results of this large observational study indicate a strong inverse association between levels of pre-diagnostic 25-(OH)D concentration and risk of colorectal cancer in western European populations. Further randomised trials are needed to assess whether increases in circulating 25-(OH)D concentration can effectively decrease the risk of colorectal cancer.
AuthorsMazda Jenab, H Bas Bueno-de-Mesquita, Pietro Ferrari, Franzel J B van Duijnhoven, Teresa Norat, Tobias Pischon, Eugène H J M Jansen, Nadia Slimani, Graham Byrnes, Sabina Rinaldi, Anne Tjønneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Sophie Morois, Rudolf Kaaks, Jakob Linseisen, Heiner Boeing, Manuela M Bergmann, Antonia Trichopoulou, Gesthimani Misirli, Dimitrios Trichopoulos, Franco Berrino, Paolo Vineis, Salvatore Panico, Domenico Palli, Rosario Tumino, Martine M Ros, Carla H van Gils, Petra H Peeters, Magritt Brustad, Eiliv Lund, María-José Tormo, Eva Ardanaz, Laudina Rodríguez, Maria-José Sánchez, Miren Dorronsoro, Carlos A Gonzalez, Göran Hallmans, Richard Palmqvist, Andrew Roddam, Timothy J Key, Kay-Tee Khaw, Philippe Autier, Pierre Hainaut, Elio Riboli
JournalBMJ (Clinical research ed.) (BMJ) Vol. 340 Pg. b5500 (Jan 21 2010) ISSN: 1756-1833 [Electronic] England
PMID20093284 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Vitamin D
  • Calcium
Topics
  • Calcium (administration & dosage)
  • Case-Control Studies
  • Colorectal Neoplasms (blood, epidemiology)
  • Diet
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Europe (epidemiology)
  • Female
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Risk Factors
  • Vitamin D (administration & dosage, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: